Skip to main content
SupplementScience

Benefits of Glutathione (Liver Support)

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Phase II detoxification — glutathione S-transferases (GSTs) conjugate electrophilic toxins, drugs (including acetaminophen), and carcinogens with glutathione, rendering them water-soluble for excretion. This is the primary detoxification pathway for hundreds of xenobiotics (Hayes et al., 2005).
  • Acetaminophen overdose protection — IV N-acetylcysteine (NAC, a glutathione precursor) is the standard-of-care treatment for acetaminophen poisoning, restoring hepatic GSH levels and preventing liver necrosis. Prescott et al. (1979, n=100) established this life-saving protocol.
  • NAFLD improvement — Honda et al. (2017, n=34) showed IV glutathione at 300mg/day for 4 months significantly reduced ALT and markers of oxidative stress in NAFLD patients.
  • Antioxidant defense — glutathione peroxidase (GPx) uses GSH to neutralize hydrogen peroxide and lipid hydroperoxides in hepatocytes, preventing oxidative damage to membranes, proteins, and DNA (Forman et al., 2009).
  • Liver disease recovery — multiple studies show GSH depletion correlates with severity of liver disease; replenishment with NAC or direct GSH supplementation supports hepatocyte function and recovery (Lu, 2013).

What the Research Says

Glutathione's role in liver health is among the most well-established in biochemistry. Hayes et al. (2005) published the definitive review on glutathione S-transferases and their role in detoxification. Prescott et al. (1979) established IV NAC as the standard treatment for acetaminophen toxicity by restoring hepatic glutathione. Honda et al. (2017) provided clinical evidence for direct glutathione supplementation in NAFLD. Lu (2013) published a comprehensive review in Biochimica et Biophysica Acta linking glutathione depletion to the pathogenesis of virtually all forms of liver disease. The key challenge with oral glutathione supplementation has been bioavailability — liposomal technology and S-acetyl forms have largely addressed this limitation, while NAC remains the most cost-effective strategy for raising hepatic GSH levels.

Related Conditions

Liver Health
Full Glutathione (Liver Support) Guide

References

  1. (). Glutathione transferases. Annual Review of Pharmacology and Toxicology. DOI
  2. (). Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. DOI
  3. (). Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterology. DOI
  4. (). Glutathione synthesis. Biochimica et Biophysica Acta. DOI